Voyager Therapeutics, Inc. (28)

Browse by Contract Category

Contracts

Option and License Agreement by and between the Registrant and Novartis Pharma AG, dated March 4, 2022 (Filed With SEC on May 4, 2022)
Employment Agreement, by and between Voyager Therapeutics, Inc. and Alfred Sandrock, M.D., Ph.D., effective as of March 22, 2022 (Filed With SEC on March 22, 2022)
Sublease Agreement, by and between Registrant and BioNTech US Inc., dated September 3, 2021 (Filed With SEC on November 2, 2021)
Description of Registrants Securities (Filed With SEC on March 3, 2020)
Amendment No. 1 to the Collaboration and License Agreement, by and between Voyager Therapeutics, Inc. and Neurocrine Biosciences, Inc., dated June 14, 2019 (Filed With SEC on August 9, 2019)
Form of Non-Qualified Stock Option Agreement for Inducement Grant (Filed With SEC on February 26, 2019)
Employment Agreement, by and between the Registrant and Julie Burek, dated as of October 1, 2021 (Filed With SEC on March 8, 2022)
Consulting Agreement by and between the Registrant and Allison Dorval, dated as of November 26, 2021 (Filed With SEC on March 8, 2022)
Separation and Release of Claims Agreement by and between the Registrant and Allison Dorval, effective December 13, 2021 (Filed With SEC on March 8, 2022)
Amended and Restated Employment Agreement, by and between Voyager Therapeutics, Inc. and Robin Swartz, effective as of February 7, 2022 (Filed With SEC on February 3, 2022)
Consulting Agreement by and between Voyager Therapeutics, Inc. and Alfred Sandrock, effective as of February 7, 2022 (Filed With SEC on February 3, 2022)
Option and License Agreement, by and between the Registrant and Pfizer Inc., dated October 1, 2021 (Filed With SEC on November 2, 2021)
Amendment No. 1 to Employment Agreement, by and between the Registrant and Glenn Pierce, dated June 7, 2021 (Filed With SEC on June 8, 2021)
Transition, Separation and Release of Claims Agreement, by and between the Registrant and G. Andre Turenne, dated May 19, 2021 (Filed With SEC on May 19, 2021)
Employment Agreement, by and between the Registrant and Glenn Pierce, M.D., Ph.D., dated May 19, 2021 (Filed With SEC on May 19, 2021)
Employment Agreement, by and between the Registrant and Michael Higgins, dated May 19, 2021 (Filed With SEC on May 19, 2021)
AMENDMENT NO. 2 TO CONSULTING AGREEMENT (Filed With SEC on February 25, 2021)
First Amendment to Amended and Restated Option and License Agreement with Genzyme Corporation, dated September 20, 2020 (Filed With SEC on November 9, 2020)
Lease Agreement, by and between the Registrant and HCP/King 75 Hayden LLC, dated March 16, 2020 (Filed With SEC on March 19, 2020)
Transition, Separation, and Release of Claims Agreement, by and between the Company and Matthew P. Ottmer, dated as of February 12, 2020 (Filed With SEC on February 14, 2020)
Amendment No. 1 to Consulting Agreement, by and between the Corporation and Dinah Sah, dated September 16, 2019 (Filed With SEC on November 6, 2019)
Amendment No. 1 to Consulting Agreement, by and between the Corporation and Steven M. Paul, M.D., dated July 9, 2019 (Filed With SEC on November 6, 2019)
Consulting Agreement, by and between Voyager Therapeutics, Inc. and Dinah Sah, Ph.D., dated June 28, 2019 (Filed With SEC on August 9, 2019)
Amended and Restated Option and License Agreement, by and between Voyager Therapeutics, Inc. and Genzyme Corporation, dated June 14, 2019 (Filed With SEC on August 9, 2019)
Termination Agreement, by and between Voyager Therapeutics, Inc. and Genzyme Corporation, dated June 14, 2019 (Filed With SEC on August 9, 2019)
Employment Agreement, by and between Voyager Therapeutics, Inc. and Omar Khwaja, M.D., Ph.D, dated May 20, 2019 (Filed With SEC on August 9, 2019)
Retirement Agreement, by and between the Company and Dinah Sah, dated as of May 20, 2019 (Filed With SEC on May 21, 2019)
Employment Agreement, by and between the Registrant and Robert W. Hesslein, dated January 15, 2019 (Filed With SEC on May 7, 2019)